Summary
Revenue rose +11.8% in 1Q, driven by higher orders in the sewing business. However, FX-adjusted operating income, which the company treats as its underlying earnings measure, fell to JPY 850M (-21.7%). The decline mainly reflected upfront costs at new lines and lower profit in the lamination film business. The key question for 2Q is whether workers on the lines added in Vietnam, Indonesia and Bangladesh climb the learning curve fast enough for sewing revenue growth to reach the bottom line. We will also watch whether the decline in lamination film yardage narrows, and whether cumulative 1H progress builds toward the full-year target of JPY 5,300M. The cash flow statement is disclosed in 2Q, so trends in inventories and short-term borrowings, both of which rose at 1Q-end, will also be important.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
Recovery in Underlying Earnings1H FX-adjusted operating income YoY and progress toward full-year plan | 1Q came in at JPY 850M, or 16.0% of the full-year plan of JPY 5,300M (our estimate). The remaining three quarters need to deliver JPY 4,450M (our estimate). |
Sewing Business ProfitabilityGrowth in sewing FX-adjusted operating income vs. revenue growth | In 1Q, revenue grew +16.2%, but FX-adjusted operating income rose only +4.1%. The focus is whether productivity gains at new lines narrow this gap. |
Lamination Film BusinessYardage sold and segment FX-adjusted operating income YoY | In 1Q, yardage fell -14.1% and FX-adjusted operating income fell -66.0%. We will track the trajectory of the profit decline as the customer mix review progresses. |
Breakdown of FX ImpactFX gains/losses by operating vs. financial transactions, and recurring profit progress vs. full-year plan | 1Q recurring profit grew +45.5%. However, the main driver was improved FX gains on financial transactions (+JPY 541M). Against the recurring profit plan of JPY 4,900M (-9.1%), FX gains on operating transactions should be assessed separately. |
Working Capital and FundingInventory balance and 1H operating CF | At 1Q-end, inventories were up JPY 2,234M from the prior fiscal year-end and short-term borrowings were up JPY 1,531M. Operating CF in 1H of the prior year was JPY 478M, and we will benchmark 1H operating CF against this level. |
Key Issues from Previous Results (1Q FY3/27)
1Q revenue was JPY 18,958M (+11.8%), driven by higher unit volumes in the sewing business. In contrast, operating income fell to JPY 148M (-28.4%) and FX-adjusted operating income fell to JPY 850M (-21.7%). Recurring profit rose to JPY 1,113M (+45.5%) on larger FX gains. Full-year guidance was left unchanged, making 2Q the quarter to verify progress toward the plan on an underlying basis.
1. Pace of Recovery in FX-adjusted Operating Income
- Previous Quarter: 1Q FX-adjusted operating income was JPY 850M (-21.7%), representing 16.0% of the full-year plan of JPY 5,300M (+10.1%) (our estimate).
- This Quarter's Check: The company cites upfront costs in the sewing business and lower lamination film profit as the drivers of the decline. In 2Q, we will check whether these factors have run their course and the YoY comparison improves.
- Key Metrics: 1H FX-adjusted operating income YoY; progress vs. the full-year plan of JPY 5,300M; HQ administrative SG&A (1Q JPY 334M vs. JPY 288M a year earlier).
2. Productivity Gains at New Sewing Lines
- Previous Quarter: The sewing business grew revenue, with units sold of 14.18M (+12.0%) and revenue of JPY 16,585M (+16.2%).
- Previous Quarter: However, FX-adjusted operating income rose only +4.1% to JPY 1,066M. The margin was 6.4%, below 7.2% a year earlier (our estimate).
- This Quarter's Check: The company attributes the modest profit growth to an increase in new lines still ramping up productivity, along with upfront costs. The focus is whether skills-upgrading initiatives translate into better 2Q profitability.
- Key Metrics: Sewing units sold YoY; gap between FX-adjusted operating income growth and revenue growth; consolidated gross profit margin (1Q 10.1% vs. 10.3% a year earlier).
3. Magnitude of the Lamination Film Profit Decline
- Previous Quarter: Yardage sold was 3.74M yards (-14.1%), with revenue of JPY 2,372M (-11.8%) and FX-adjusted operating income of JPY 119M (-66.0%).
- This Quarter's Check: Drivers included a weak Chinese market and delayed demand recovery, as well as a review of the key customer mix. We will check whether the review has run its course and volume declines are bottoming out.
- Key Metrics: Yardage sold YoY; segment FX-adjusted operating income (JPY 349M in 1Q of the prior year); segment profit.
4. FX Gain/Loss Composition and Recurring Profit Plan
- Previous Quarter: The FX gain of JPY 889M comprised JPY 702M from operating transactions (-20.1%) and JPY 187M from financial transactions (vs. -JPY 354M a year earlier).
- Previous Quarter: The increase in recurring profit was mainly due to the improvement on financial transactions. Progress against the full-year recurring profit plan of JPY 4,900M stands at 22.7% (our estimate).
- This Quarter's Check: The company plan implies FX-adjusted operating income exceeding operating income by JPY 1,900M (our estimate). We will check how much of this gap the 1Q operating-transaction FX gain of JPY 702M covers, and how it accumulates.
- Key Metrics: FX gains/losses by operating vs. financial transactions; 1H recurring profit (JPY 2,544M a year earlier); foreign currency translation adjustment (JPY 9,090M at 1Q-end).
- 2Q of the prior year included an extraordinary loss of JPY 265M. For the 1H net income comparison, we will review the breakdown of extraordinary items and income taxes.
5. Inventory Build and Funding
- Previous Quarter: Inventories stood at JPY 17,846M at 1Q-end, up JPY 2,234M from the prior fiscal year-end. Notes and accounts payable rose JPY 2,341M and short-term borrowings rose JPY 1,531M.
- This Quarter's Check: Work in progress accounted for a large share of the inventory increase at +JPY 1,638M. We will check whether this reflects higher production on order growth, and whether it converts into revenue in 2Q so that balances normalize.
- Key Metrics: Inventory balance at 2Q-end; 1H operating CF (JPY 478M a year earlier); borrowings (JPY 15,060M at 1Q-end, sum of short- and long-term borrowings, our estimate).
Key Timely Disclosures During the Period
- 2026/10/01IR Seminar for Retail Investors (Progress on Medium-Term Management Plan "BEYOND 2028") - The new Indonesian factory is scheduled to break ground this fiscal year, with test production slated to begin around January 2028. The plan calls for a 3M-unit capacity increase. The P&L contribution is expected from 4Q FY3/28 onward, so in 2Q the focus will be on capex progress.
- 2026/08/17Trade Press Reports Solid 1Q Orders and Capacity Expansion - Reports highlighted rising orders for fan-equipped workwear and the capture of demand through capacity expansion in three countries. Sustained order momentum is the focus for 2Q.
- 2026/08/07Supplementary Materials for 1Q FY3/27 Financial Results - 1Q revenue hit a record high for a first quarter. Supply capacity in the sewing business expanded, while lamination film revenue declined. In 2Q, we will monitor profit trends in both businesses.
Previous Quarter Results (1Q FY3/27 Actual)
The company operates two segments: sewing and lamination film. The sewing business has production bases in Vietnam, Indonesia and Bangladesh and accounts for roughly 87% of revenue (our estimate). In 1Q, higher sewing revenue lifted consolidated revenue +11.8%. However, upfront costs and lower lamination film profit drove FX-adjusted operating income down -21.7%. The earnings release contains no medium-term plan targets, so we benchmark against the unchanged full-year guidance (Revenue JPY 80,000M; FX-adjusted Operating Income JPY 5,300M).
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 18,958M | +11.8% | 23.7% of FY Plan | Sewing +16.2%; Lamination Film -11.8% |
| Operating Income | JPY 148M | -28.4% | 4.4% of FY Plan | SG&A +14.2% (our estimate) |
| FX-adjusted Operating Income | JPY 850M | -21.7% | 16.0% of FY Plan | Upfront costs in sewing; lower lamination film profit |
| Recurring Profit | JPY 1,113M | +45.5% | 22.7% of FY Plan | FX gain of JPY 889M (JPY 524M a year earlier) |
| Quarterly Net Income Attributable to Owners of Parent Company | JPY 549M | +63.1% | 16.2% of FY Plan | No extraordinary items recorded |
| EPS | JPY 52.36 | +62.1% | 16.2% of FY Plan | Company forecast: JPY 323.85 |
*Progress vs. full-year plan is our estimate.
Guidance Achievement Rate (Recurring Profit Basis): 22.7% (Prior-Year Period: 14.2%)
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.